| Rapid diagnosis of Mycobacterium tuberculosis with Truenat MTB: a near-care approach C Nikam, M Jagannath, MM Narayanan, V Ramanabhiraman, M Kazi, ... PloS one 8 (1), e51121, 2013 | 126 | 2013 |
| Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai M Kazi, L Drego, C Nikam, K Ajbani, R Soman, A Shetty, C Rodrigues European Journal of Clinical Microbiology & Infectious Diseases 34, 467-472, 2015 | 95 | 2015 |
| Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis C Nikam, M Kazi, C Nair, M Jaggannath, M Manoj, R Vinaya, A Shetty, ... International journal of mycobacteriology 3 (3), 205-210, 2014 | 87 | 2014 |
| Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables P Kambli, K Ajbani, C Nikam, M Sadani, A Shetty, Z Udwadia, ... The International Journal of Mycobacteriology 5 (1), 1-6, 2016 | 67 | 2016 |
| Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments K Ajbani, C Nikam, M Kazi, C Gray, C Boehme, K Balan, A Shetty, ... PloS one 7 (11), e49433, 2012 | 57 | 2012 |
| Correlating minimum inhibitory concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay P Kambli, K Ajbani, M Sadani, C Nikam, A Shetty, Z Udwadia, TC Rodwell, ... Tuberculosis 95 (2), 137-141, 2015 | 48 | 2015 |
| Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations P Kambli, K Ajbani, M Sadani, C Nikam, A Shetty, Z Udwadia, ... Diagnostic microbiology and infectious disease 82 (1), 49-53, 2015 | 38 | 2015 |
| Imported SARS-CoV-2 V501Y. V2 variant (B. 1.351) detected in travelers from South Africa and Tanzania to India PD Yadav, N Gupta, DA Nyayanit, RR Sahay, AM Shete, T Majumdar, ... Travel Medicine and Infectious Disease 41, 102023, 2021 | 37 | 2021 |
| Can inhA mutation predict ethionamide resistance? V Vadwai, K Ajbani, M Jose, VP Vineeth, C Nikam, M Deshmukh, A Shetty, ... The International journal of tuberculosis and lung disease 17 (1), 129-130, 2013 | 24 | 2013 |
| SARS-CoV-2 seroprevalence in 12 cities of India from July-December 2020 A Velumani, C Nikam, W Suraweera, SH Fu, H Gelband, P Brown, ... medRxiv, 2021.03. 19.21253429, 2021 | 18 | 2021 |
| Redefining MTBDRplus test results: what do indeterminate results actually mean? C Nikam, R Patel, M Sadani, K Ajbani, M Kazi, R Soman, A Shetty, ... The International Journal of Tuberculosis and Lung Disease 20 (2), 154-159, 2016 | 18 | 2016 |
| Dual‐tubed multiplex‐PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp. M Kazi, C Nikam, A Shetty, C Rodrigues Journal of applied microbiology 118 (5), 1096-1102, 2015 | 17 | 2015 |
| Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations P Kambli, K Ajbani, C Nikam, A Khillari, A Shetty, Z Udwadia, ... The International Journal of Tuberculosis and Lung Disease 19 (10), 1227-1229, 2015 | 14 | 2015 |
| Is a composite reference standard (CRS) an alternative to culture in assessment and validation of a single tube nested in-house PCR for TB diagnosis? M Deshmukh, C Nikam, T Ragte, A Shetty, C Rodrigues Egyptian Journal of Chest Diseases and Tuberculosis 62 (4), 805-815, 2013 | 13 | 2013 |
| SARS-CoV-2 testing in low-and middle-income countries: availability and affordability in the private health sector L Faust, AJ Zimmer, M Kohli, S Saha, J Boffa, ML Bayot, I Nsofor, ... Microbes and Infection 22 (10), 511, 2020 | 11 | 2020 |
| Rifampicin-resistant tuberculosis: what is the best initial empiric regimen in Mumbai, India? JB Mullerpattan, C Nikam, U Sharma, C Rodrigues, LM Pinto European Respiratory Journal 50 (1), 2017 | 6 | 2017 |
| Multidrug-resistant tuberculosis with fluoroquinolone resistance: sinister association with other drugs and ominous implications for treatment K Ajbani, C Nikam, A Shetty, R Soman, C Rodrigues Clinical Infectious Diseases 59 (1), 138-139, 2014 | 5 | 2014 |
| Cytomegalovirus in Indian systemic lupus erythematosus patients: troublemaker or onlooker? S Dubey, C Rodrigues, C Nikam, R Samant Pan African Medical Journal 37 (1), 2020 | 4 | 2020 |
| Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line … P Kambli, K Ajbani, C Nikam, M Sadani, A Shetty, Z Udwadia, ... The International Journal of Mycobacteriology 5 (3), 370-372, 2016 | 4 | 2016 |
| Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India V Rana, N Singh, C Nikam, P Kambli, PK Singh, U Singh, A Jain, ... Infection and Drug Resistance, 1717-1732, 2022 | 3 | 2022 |
Christen M GrayAstraZenecaVerified email at alum.mit.edu
